Engineering of stepwise-targeting chitosan oligosaccharide conjugate for the treatment of acute kidney injury

Dong-Wei Wang,Shu-Juan Li,Xue-Ying Tan,Jin-Hui Wang,Ying Hu,Zeng Tan,Jing Liang,Jing-Bo Hu,Yan-Guo Li,Yu-Fen Zhao
DOI: https://doi.org/10.1016/j.carbpol.2020.117556
IF: 10.723
2021-03-01
Carbohydrate Polymers
Abstract:<p>Acute kidney injury (AKI) is a common and serious clinical syndrome of acute renal dysfunction in a short period. One of therapeutic interventions for AKI is to reduce ROS massively generated in the mitochondria and then ameliorate cell damage and apoptosis induced by oxidative stress. In this study, stepwise-targeting chitosan oligosaccharide, triphenyl phosphine-low molecular weight chitosan-curcumin (TPP-LMWC-CUR, TLC), was constructed for sepsis-induced AKI via removing excessive ROS in renal tubular epithelial cells. Benefiting from good water solubility and low molecular weight, TLC was rapidly and preferentially distributed in the renal tissues and then specifically internalized by tubular epithelium cells via interaction between Megalin receptor and LMWC. The intracellular TLC could further delivery CUR to mitochondria due to high buffering capacity of LMWC and delocalized positive charges of TPP. Both <em>in vitro</em> and <em>in vivo</em> pharmacodynamic results demonstrated the enhanced therapeutic effect of TLC in the treatment of AKI.</p>
polymer science,chemistry, organic, applied
What problem does this paper attempt to address?